Repro Med Systems Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -19.5% | -3.4% | -0.7% | +0.3% | -0.6% | 0.0% | -6.2% | +6.2% | +4.0% | +1.4% | -2.2% | |
| – | -6.6% | -3.8% | -0.6% | -2.3% | +1.1% | -0.7% | -7.5% | +10.5% | +2.9% | +3.0% | -5.2% | |
| – | +6.6% | -5.8% | -3.3% | -15.8% | +8.8% | -8.8% | -7.8% | +5.1% | +4.8% | -1.2% | -5.5% | |
| – | +6.6% | -5.8% | -3.3% | -15.8% | +8.8% | -8.8% | -7.8% | +5.1% | +4.8% | -1.2% | -5.5% | |
| – | -0.1% | +15.7% | +24.9% | -10.4% | +14.5% | +4.5% | -18.8% | +8.3% | +18.4% | -3.2% | -3.6% | |
| – | -25.6% | -9.6% | -17.7% | +51.7% | -28.6% | +16.9% | +20.4% | +11.7% | -16.6% | +21.7% | +0.8% | |
| – | -0.5% | -2.2% | +1.0% | +0.2% | -2.1% | -1.9% | -2.4% | -2.5% | +0.5% | +3.9% | +133.9% | |
| – | +2.3% | +3.4% | +2.6% | +12.3% | +7.7% | +4.5% | -17.3% | +18.3% | +4.8% | +4.6% | -15.1% | |
| – | +5.5% | +8.9% | +5.9% | +23.1% | +13.9% | +8.3% | -22.4% | +29.5% | +4.6% | +8.0% | -18.9% | |
| – | -14.3% | -18.9% | -21.5% | +80.9% | -13.7% | -16.3% | -19.9% | +64.6% | -38.0% | +1.8% | +5.6% | |
| – | +3.1% | +81.9% | -10.1% | +4.7% | -1.2% | +22.0% | -45.6% | +71.0% | +21.1% | +16.2% | +10.5% | |
| – | -25.8% | -6.1% | -2.2% | -5.2% | -5.2% | -2.8% | +1.1% | -0.4% | +3.5% | -0.7% | +6.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | +0.1% | +0.2% | +0.1% | +0.1% | +0.2% | +0.5% | +0.1% | -0.1% | +0.4% | +6.8% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.